99 related articles for article (PubMed ID: 14612150)
1. Interactions of cations and anions with the binding of uptake blockers to the dopamine transporter.
Bonnet JJ
Eur J Pharmacol; 2003 Oct; 479(1-3):199-212. PubMed ID: 14612150
[TBL] [Abstract][Full Text] [Related]
2. Binding of uptake blockers to the neuronal dopamine transporter: further investigation about cationic and anionic requirements.
Corera AT; Costentin J; Bonnet JJ
Naunyn Schmiedebergs Arch Pharmacol; 2000 Sep; 362(3):213-21. PubMed ID: 10997723
[TBL] [Abstract][Full Text] [Related]
3. Dynamic regulation of the dopamine transporter.
Mortensen OV; Amara SG
Eur J Pharmacol; 2003 Oct; 479(1-3):159-70. PubMed ID: 14612147
[TBL] [Abstract][Full Text] [Related]
4. Cations affect [3H]mazindol and [3H]WIN 35,428 binding to the human dopamine transporter in a similar fashion.
Wu Q; Coffey LL; Reith ME
J Neurochem; 1997 Sep; 69(3):1106-18. PubMed ID: 9282933
[TBL] [Abstract][Full Text] [Related]
5. Studies of the biogenic amine transporters. VIII: identification of a novel partial inhibitor of dopamine uptake and dopamine transporter binding.
Rothman RB; Dersch CM; Carroll FI; Ananthan S
Synapse; 2002 Mar; 43(4):268-74. PubMed ID: 11835522
[TBL] [Abstract][Full Text] [Related]
6. Regulation of dopamine transporter function and plasma membrane expression by dopamine, amphetamine, and cocaine.
Kahlig KM; Galli A
Eur J Pharmacol; 2003 Oct; 479(1-3):153-8. PubMed ID: 14612146
[TBL] [Abstract][Full Text] [Related]
7. Mutation of Trp84 and Asp313 of the dopamine transporter reveals similar mode of binding interaction for GBR12909 and benztropine as opposed to cocaine.
Chen N; Zhen J; Reith ME
J Neurochem; 2004 May; 89(4):853-64. PubMed ID: 15140185
[TBL] [Abstract][Full Text] [Related]
8. Effect of CH3HgCl and several transition metals on the dopamine neuronal carrier; peculiar behaviour of Zn2+.
Bonnet JJ; Benmansour S; Amejdki-Chab N; Costentin J
Eur J Pharmacol; 1994 Jan; 266(1):87-97. PubMed ID: 8137886
[TBL] [Abstract][Full Text] [Related]
9. Complex ionic control of [3H]GBR 12783 binding to the dopamine neuronal carrier.
Héron C; Billaud G; Costentin J; Bonnet JJ
Eur J Pharmacol; 1996 Apr; 301(1-3):195-202. PubMed ID: 8773464
[TBL] [Abstract][Full Text] [Related]
10. Recognition of benztropine by the dopamine transporter (DAT) differs from that of the classical dopamine uptake inhibitors cocaine, methylphenidate, and mazindol as a function of a DAT transmembrane 1 aspartic acid residue.
Ukairo OT; Bondi CD; Newman AH; Kulkarni SS; Kozikowski AP; Pan S; Surratt CK
J Pharmacol Exp Ther; 2005 Aug; 314(2):575-83. PubMed ID: 15879005
[TBL] [Abstract][Full Text] [Related]
11. Dopamine transporter as target for drug development of cocaine dependence medications.
Dutta AK; Zhang S; Kolhatkar R; Reith ME
Eur J Pharmacol; 2003 Oct; 479(1-3):93-106. PubMed ID: 14612141
[TBL] [Abstract][Full Text] [Related]
12. Cationic modulation of human dopamine transporter: dopamine uptake and inhibition of uptake.
Chen N; Trowbridge CG; Justice JB
J Pharmacol Exp Ther; 1999 Sep; 290(3):940-9. PubMed ID: 10454463
[TBL] [Abstract][Full Text] [Related]
13. Interaction between dopamine and its transporter: role of intracellular sodium ions and membrane potential.
Chen N; Reith ME
J Neurochem; 2004 May; 89(3):750-65. PubMed ID: 15086531
[TBL] [Abstract][Full Text] [Related]
14. Is Na(+) required for the binding of dopamine, amphetamine, tyramine, and octopamine to the human dopamine transporter?
Li LB; Cui XN; Reith MA
Naunyn Schmiedebergs Arch Pharmacol; 2002 Apr; 365(4):303-11. PubMed ID: 11919655
[TBL] [Abstract][Full Text] [Related]
15. Effects of dopamine transporter inhibitors on cocaine self-administration in rhesus monkeys: relationship to transporter occupancy determined by positron emission tomography neuroimaging.
Lindsey KP; Wilcox KM; Votaw JR; Goodman MM; Plisson C; Carroll FI; Rice KC; Howell LL
J Pharmacol Exp Ther; 2004 Jun; 309(3):959-69. PubMed ID: 14982963
[TBL] [Abstract][Full Text] [Related]
16. Dopamine transporter tryptophan mutants highlight candidate dopamine- and cocaine-selective domains.
Lin Z; Wang W; Uhl GR
Mol Pharmacol; 2000 Dec; 58(6):1581-92. PubMed ID: 11093799
[TBL] [Abstract][Full Text] [Related]
17. Cationic interactions at the human dopamine transporter reveal binding conformations for dopamine distinguishable from those for the cocaine analog 2 alpha-carbomethoxy-3 alpha-(4-fluorophenyl)tropane.
Chen N; Sun L; Reith ME
J Neurochem; 2002 Jun; 81(6):1383-93. PubMed ID: 12068085
[TBL] [Abstract][Full Text] [Related]
18. Dissociation of high-affinity cocaine analog binding and dopamine uptake inhibition at the dopamine transporter.
Wang W; Sonders MS; Ukairo OT; Scott H; Kloetzel MK; Surratt CK
Mol Pharmacol; 2003 Aug; 64(2):430-9. PubMed ID: 12869648
[TBL] [Abstract][Full Text] [Related]
19. Effect of dopamine uptake inhibition on brain catecholamine levels and locomotion in catechol-O-methyltransferase-disrupted mice.
Huotari M; Santha M; Lucas LR; Karayiorgou M; Gogos JA; Männistö PT
J Pharmacol Exp Ther; 2002 Dec; 303(3):1309-16. PubMed ID: 12438556
[TBL] [Abstract][Full Text] [Related]
20. Inhibition by arachidonic acid and other fatty acids of dopamine uptake at the human dopamine transporter.
Chen N; Appell M; Berfield JL; Reith ME
Eur J Pharmacol; 2003 Oct; 478(2-3):89-95. PubMed ID: 14575792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
